课题基金 / 基金详情

Role of alphaEbeta7 on tissue destruction of autoimmune diseases

Role of alphaEbeta7 on tissue destruction of autoimmune diseases
alphaEbeta7 在自身免疫性疾病组织破坏中的作用
批准号:
09670491
负责人:
TAKEUCHI Tsutomu
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TAKEUCHI Tsutomu的其他基金

相似基金

相关文献

中文摘要
翻译
为了表征激活的PBL及其在SLE发病机制中的作用,我们开发了一系列针对SLE PBL表面结构的单克隆抗体。我们重点研究了一种名为SM-17的单克隆抗体,它能在CD8+T细胞上与活化抗原反应。免疫沉淀分析清楚地表明SM-17识别的抗原为α ^Ebeta_7 (cd103),这是首次在上皮内淋巴细胞上鉴定到的表面抗原。检测了α ^Ebeta_7 (cd103)在多种自身免疫和血液病患者有或没有PHA刺激时的表达。我们发现alpha^Ebeta_7 (cd103)的表达在系统性红斑狼疮患者和1例毛细胞白血病患者在没有刺激的情况下显著升高。不仅CD8+ T细胞表达增强,SLE患者的CD4+ T细胞也表达增强。cd103的表达增强与口腔溃疡或浆液炎的存在显著相关,提示其可能涉及这些部位的组织损伤。对HSG上皮细胞系的黏附实验表明,cd103表达增强的T细胞对HSG有较强的黏附,可被抗α ^Ebeta_7抗体部分阻断。这些结果表明这种新型整合蛋白在组织损伤中的作用,特别是上皮细胞,上皮细胞表达E-cadherin, cd103的高表达。
英文摘要
To characterize the activated PBL and the role on pathogenesis in SLE, we have developed a series of monoclonal antibodies directed against the surface structures on the SLE PBL.We focused on the one monoclonal antibody designated SM-17, which reacted to the activation antigen on CD8+T cells. immunoprecipitation analysis clearly showed that the antigen recognized by SM-17 was alpha^Ebeta_7 (CD 103), which was first identified the surface antigen on the intra-epithelial lymphocytes. The expression of alpha^Ebeta_7 (CD 103) was examined in the a variety of autoimmtme and hematological patients with or without stimulation of PHA.We found that the expression of alpha^Ebeta_7 (CD 103) was significantly elevated in patients with SLE after stimulation with PHA, and one patient with hairy cell leukemia in the absence of stimulation. The enhanced expression was not only observed in CD8+ T cells, but also in CD4+ T cells from SLE patients. Th enhanced expression of CD 103 is significantly correlated with the presence of oral ulcers or serositis, suggesting that it may involve in tissue injury in these sites. Adhesion experiments against the HSG epithelial cell lines showed that the T cells with enhanced expression of CD 103 strongly adhered onto HSG, which was partially blocked by anti-alpha^Ebeta_7 antibody. These results suggest a role of this novel inte grin on the tissue injury, particularly epithelial cells, which are expressing E-cadherin, a higand for CD 103.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
Takeuchi T,Pang M,Amano K,Koide J,and Abe T.: "Reduced protein tyrosine phosphatase activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus." Clin Exp Immunol. 109. 20-26 (1997)
Takeuchi T、Pang M、Amano K、Koide J 和 Abe T.:“系统性红斑狼疮患者外周血淋巴细胞上 CD45 的蛋白酪氨酸磷酸酶活性降低。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Parg M.,et al.: "Upregulation of αEβ7,a novel integrin adhesion molecale,on T cells from SLE patients with specific epithelial involvement" Arthritis and Rheumatism. 41・7. 1456-1463 (1998)
Parg M. 等人:“αEβ7(一种新型整合素粘附分子)对具有特定上皮受累的 SLE 患者的 T 细胞的上调”关节炎和风湿病 1456-1463。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuzaka K.,et al.: "Mutation in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients." J Autoimmunity. 11・11. 381-385 (1998)
Tsuzaka K. 等人:“系统性红斑狼疮患者外周 T 细胞的 T 细胞受体 Zeta 链 mRNA 突变”,《自身免疫杂志》11・11(1998 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujihara T.,et al.: "Serum soluble FAS/APO-1 is increased in patients with primary sjo'gren's syndrome" Clin Rheumatology. 17・6. 496-499 (1998)
Fujihara T.等人:“原发性干燥综合征患者的血清可溶性FAS/APO-1增加”《临床风湿病学》17・6(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 31 条
    Molecular signatures in pre-RA patients by multi-omics analysis
    • 批准号:
      20H03720
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2020
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Identification and characterization of pathogenesis related molecules in early rheumatoid arthritis by DNA microarray
    • 批准号:
      23390259
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Analysis on signal transduction pathway through CD103 molecule
    • 批准号:
      20591193
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    Construction of a galaxy SED model consistent with chemical evolution
    • 批准号:
      20740105
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.91万
    • 财政年份:
      2008
    • 负责人:
      TAKEUCHI Tsutomu
    • 依托单位:
    国内基金
    海外基金
    mir-125b在1型糖尿病自身免疫性胰岛炎中的作用及机制研究
    • 批准号:
      30901627
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2009
    • 负责人:
      韩蓓
    • 依托单位: